Enantioselective synthesis of N-Cbz-protected 6-amino-6-deoxymannose, -talose, and -gulose

Organic Letters

Volumn 3, Issue 24, 2001, Pages 3899-3902

  Haukaas, Michael H ^a   O'Doherty, George A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINO 6 DEOXYGLUCOPYRANOSE; 6 AMINO 6 DEOXYMANNOSE; 6 AMINO 6 DEOXYTALOSE; 6-AMINO-6-DEOXYGLUCOPYRANOSE; 6-AMINO-6-DEOXYMANNOSE; 6-AMINO-6-DEOXYTALOSE; AMINOSUGAR; DRUG DERIVATIVE; GLUCOSAMINE; RHAMNOSE;

ARTICLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

AMINO SUGARS; GLUCOSAMINE; MAGNETIC RESONANCE SPECTROSCOPY; RHAMNOSE; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T;

EID: 0035969619     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol016743m     Document Type: Article

References (51)

1. Goodman-Gilman, A.; Goodman; L. S.; Rall, T. W.; Murad, F. Goodman and Gilman's The Pharmacological Basis of Therapeutics; MacMillan Publishing Co: New York, 1985.
2. For the first synthesis of kanamycin A, see: Nakajima, M. Hasegawa, A. Kurihara, N.; Shibata, H.; Ueno, T.; Nishumura, D. Tetrahedron Lett. 1968, 9, 623-627.
3. Hooper, I. R. The Naturally Occurring Aminoglycoside Antibiotics. In Aminoglycoside Antibiotics; Hooper, I. R., Umezawa, H., Eds.; Springer-Verlag: New York, 1982.
4. Ruppersberg, J. P. HNO 1997, 45(3), 111-112.
5. Brickner, S. J. Chem. Ind. 1997, 131-135.
6. (a) Green, M. R. AIDS Res. Rev. 1993, 3, 41-55.
7. (b) Alper, P. B.; Hendrix, M.; Sears, P.; Wong, C.-H. J. Am. Chem. Soc. 1998, 120, 1965-1978.
8. Miller, G. H.; Sabatelli, F. J.; Hare, R. S.; Glupczynski, Y.; Mackey, P.; Shlaes, D.; Shimizu, K.; Shaw, K. J.; Bauernfeind, A.; Schweighart, S.; Shannon, K.; Patzer, J.; Molinari, G.; Schito, G. C.; Gomezlus, R.; Gomezlus, S.; Ferreira, H.; Sousa, J. C.; Vaz, M. J. M.; Collatz, E.; Bismuth, R.; Lambert, T.; Courvalin, P.; Minozzi, C.; Kluaman, K. Clin. Infect. Dis. 1997, 24, S 46-S 62.
9. For instance, worldwide Streptococcus pneumoniae is responsible for 1.2 million deaths per year in children under the age of 5, see: (a) Bruyn G. A. W.; Zegers, B. J. M.; van Furth, R. Clin. Infect. Dis. 1992, 14, 251-262.
10. (b) Janoff, E. N.; Rubins, J. B. Microb. Drug Resist. 1997, 3, 215-232. Even more alarming is that Mycobacterium tuberculosis is estimated to cause 3 million deaths per year, see:
11. (c) Swartz, M. N. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 2420-2427.
12. Umezawa, H.; Kondo, S. Mechanisms of Resistance to Aminoglycoside Antibiotics. In Aminoglycoside Antibiotics; Hooper, I. R., Umezawa, H., Eds.; Springer-Verlag: New York, 1982.
13. Roestamadji, J.; Grapsas, I.; Mobashery, S. J. Am. Chem. Soc. 1995, 117, 11060-11074.
14. (a) Umezawaa, S.; Tsuchiya, T. Total Synthesis and Chemical Modification of the Aminoglycoside Antibiotics. In Aminoglycoside Antibiotics; Hooper, I. R., Umezawa, H., Eds.; Springer-Verlag: NewYork, 1982.
15. (b) Okuda, T. Ito, Y. Biosynthesis and Mutasynthesis of Aminoglycoside Antibiotics. In Aminoglycoside Antibiotics; Hooper, I. R., Umezawa, H., Eds.; Springer-Verlag: NewYork, 1982.
16. (a) Harris, J. M.; Keranen, M. D.; O'Doherty, G. A. J. Org. Chem. 1999, 64, 2982-2983.
17. (b) Harris, J. M.; Keranen, M. D.; Nguyen, H.; Young, V. G.; O'Doherty, G. A. Carbohydr. Res. 2000, 328, 17-36.
18. Haukaas, M. H.; O'Doherty, G. A. Org. Lett. 2001, 3, 401-404.
19. Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483-2547.
20. (a) Sharpless, K. B.; Patrick, D. W.; Truesdale, L. K.; Biller, S. A. J. Am. Chem. Soc. 1975, 97, 2305-2306.
21. (b) Li, G.; Chang, H.-T.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 451-454.
22. An Achmatowicz reaction is the oxidative rearrangement of furfuryl alcohols to 2-substituted 6-hydroxy-2H-pyran-3(6H)-ones. (a) Achmatowicz, O.; Bielski, R. Carbohydr. Res. 1977, 55, 165-176.
23. (b) Grapsas, I., K.; Couladouros, E. A.; Georgiadis, M. P. Pol. J. Chem. 1990, 64, 823-826. For its use in carbohydrate synthesis, see: ref 12 and the following.
24. (c) Balachari, D.; O'Doherty, G. A. Org. Lett. 2000, 2, 863-866.
25. (d) Balachari, D.; O'Doherty, G. A. Org. Lett. 2000, 2, 4033-4036.
26. (a) Ponpipom, M. M.; Hanessian, S. Can. J. Chem. 1972, 50, 246-252.
27. (b) Ponpipom, M. M.; Hanessian, S. Can. J. Chem. 1972, 50, 253-258.
28. Recently, Herscovici reported the use of this approach to structures related to 2 by a six-step route from triacetyl-D-glucal, see: Herscovici, J.; Egron, M. J.; Quenot, A.; Leclercq, F.; Leforestier, N.; Mignet, N.; Wetzer, B.; Scherman, D. Org. Lett. 2001, 3, 1893-1896.
29. This is an improved procedure and yield from our previously published results, see: Bushey, M. L.; Haukaas, M. H.; O'Doherty, G. A J. Org. Chem. 1999, 64, 2984-2985.
30. At a smaller scale, the level of enantio-induction has been as high as 94%, as determined by Mosher ester analysis. (a) Sullivan, G. R.; Dale, J. A.; Mosher, H. S. J. Org. Chem. 1973, 38, 2143-2147.
31. (b) Yamaguchi, S.; Yasuhara, F.; Kabuto, K. T. Tetrahedron 1976, 32, 1363-1367.
32. Tao, B.; Schlingloff, G.; Sharpless, K. B. Tetrahedron Lett. 1998, 39, 2507-2510.
33. The absolute stereochemistry and the level of enantioexcesses of 3 and 6 were determined by the method of Mosher, see ref 20a.
34. Our optimized variation from the typical Sharpless procedure was to the use the sodium salt of N-chlorobenzylcarbamate as the limiting reagent, providing a good yield of a mixture of regioisomers (74%). Thus, the volatile and inexpensively produced vinylfuran in 30% excess allowed for more efficient use of the more costly catalyst and chiral ligand. This procedure routinely provided a ∼40% yield of the furfuryl alcohol 3 and a 21% yield of the TBS-protected regioisomer, see ref 19.
35. Youn, S. W.; Kim, Y. H. Synlett 2000, 880-882.
36. (a) Iseki, K.; Oishi, S.; Sasai, H.; Shibasaki, M. Tetrahedron Lett. 1996, 37, 9081-9084.
37. (b) Sasai, H.; Tokunaga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem. 1995, 60, 7388-7389.
38. (a) Yadav, J. S.; Reddy, P. T.; Hashim, S. R. Synlett 2000, 1049-1051.
39. (b) Corey, E. J.; Helal, C. J. Angew. Chem., Int. Ed. 1998, 37, 1986-2012.
40. In our hands, the TON (turn over numbers) for the catalytic (10%) use of the oxazaborolidine was too low for practical use.
41. (a) Fujii, A.; Hashiguchi, S.; Uematsu, N.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 118, 2521-2522. For catalyst preparation, see:
42. (b) Haack, K.-J.; Hashiguchi, S.; Fujii, A.; Ikariya, T.; Noyori, R. Angew. Chem., Int. Ed. Engl. 1997, 36, 285-288.
43. 2H at elevated temperatures (50 °C) with no reduction in enantiopurity and yield, see: Cossy, J.; Eustache, F.; Dalko, P. I. Tetrahedron Lett. 2001, 42, 5005-5007.
44. The preceding reaction sequences have been preformed on both (+)-3 and (-)-3; for simplicity reasons we are only drawing the results for (+)-3.
45. By performing the reaction at higher temperatures (0 °C), the minor isomer pivaloate 14β could also be obtained in higher yields as part of a 3:2 ratio, still favoring of the α-anomer 14α. At this point the anomers were separated by medium-pressure liquid chromatography (MPLC, 20% EtOAc/hexanes, UV detection) which produced baseline separation.
46. A simpler purification procedure resulted by carrying the ∼8% impurity of the minor diastereoisomer through to the reduction step. The β-anomer 14β presumably hydrolyzed when subjected to the Luche conditions; thus when samples of 14α were reduced with small amounts of the β-anomer present, only diastereomerically pure samples of 2 were detected after silica gel chromatography.
47. (a) Martin, S. P.; Dodge, J. A.Tetrahedron Lett. 1991, 32, 3017-3020.
48. (b) Grynkiewicz, G. Pol. J. Chem. 1979, 53, 2501.
49. (c) Mitsunobu, O. Compr. Org. Synth. 1991, 6, 1-32.
50. The relative stereochemistry of the p-nitrobenzoate ester was confirmed by single-crystal X-ray analysis, see Supporting Information.
51. Donohoe, T. J.; Moore, P. R.; Waring, M. J.; Newcombe, N. J. Tetrahedron Lett. 1997, 38, 5027-5030.